Literature DB >> 6202721

Platelet and coagulation factors in proliferative diabetic retinopathy.

D Q Borsey, C V Prowse, R S Gray, J Dawes, K James, R A Elton, B F Clarke.   

Abstract

Plasma beta-thromboglobulin, platelet factor 4, fibrinogen, fibrinopeptide A, antithrombin III, factor VIII related antigen, alpha 2-macroglobulin, platelet count, and total glycosylated haemoglobin were measured in three well matched groups of subjects: non-diabetic controls, diabetics without retinopathy, and diabetics with proliferative retinopathy. beta-thromboglobulin and platelet factor 4 concentrations were significantly higher in the diabetics with retinopathy than in the controls and platelet factor 4 was also increased in the diabetics without retinopathy compared with controls. Fibrinogen concentration was raised in diabetics without retinopathy compared with controls, diabetics with retinopathy compared with controls, and diabetics with retinopathy compared with those without. Fibrinopeptide A concentration did not differ significantly between groups. Antithrombin III levels were increased in diabetics with retinopathy compared with controls, and in diabetics with retinopathy compared with those without. Factor VIII related antigen values were higher in both the diabetic groups when compared with the controls. Fibrinopeptide A concentration correlated with both beta-thromboglobulin and platelet factor 4 in each of the three groups. Haemostatic abnormalities in diabetes have been shown, although a hypercoagulable state has not been confirmed. These changes in platelet and coagulation function may be secondary to the development of microvascular disease and their role in the pathogenesis of retinopathy remains uncertain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202721      PMCID: PMC498841          DOI: 10.1136/jcp.37.6.659

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  47 in total

1.  A quick and accurate method for the determination of fibronogen in plasma.

Authors:  B C ELLIS; A STRANSKY
Journal:  J Lab Clin Med       Date:  1961-09

2.  Serum concentration of alpha-2-macroglobulin, haptoglobin and alpha-1-antitrypsin in diabetes mellitus.

Authors:  P O Ganrot; K Gydell; H Ekelund
Journal:  Acta Endocrinol (Copenh)       Date:  1967-07

3.  Increased von Willebrand-antihaemophilic factor a in diabetic retinopathy.

Authors:  M Pandolfi; L O Almér; L Holmberg
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

4.  Familial thrombosis due to antithrombin 3 deficiency.

Authors:  E Marciniak; C H Farley; P A DeSimone
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

5.  Antithrombin 3 deficiency in maturity onset diabetes mellitus and atherosclerosis.

Authors:  R N Banerjee; A L Sahni; V Kumar; M Arya
Journal:  Thromb Diath Haemorrh       Date:  1974-05-15

6.  The release of platelet factor 4 during platelet aggregation and the possible significance of this reaction in hemostasis.

Authors:  S Niewiarowski; B Lipiński; R Farbiszewski; A Poplawski
Journal:  Experientia       Date:  1968-04-15

7.  Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

Authors:  E E Mayne; J M Bridges; J A Weaver
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

8.  Letter: Factor-VIII complex and endothelial damage.

Authors:  B Boneu; M Abbal; J Plante; R Bierme
Journal:  Lancet       Date:  1975-06-28       Impact factor: 79.321

9.  Influence of fibrinogen on the aggregation of washed human blood platelets induced by adenosine diphosphate, thrombin, collagen, and adrenaline.

Authors:  N O Solum; H Stormorken
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

10.  Platelet factor 4(PF4) release during human platelet aggregation in diabetic patients.

Authors:  J Chmielewski; R Farbiszewski
Journal:  Thromb Diath Haemorrh       Date:  1970-10-31
View more
  8 in total

1.  Retinal cotton-wool spots: an early finding in diabetic retinopathy?

Authors:  M S Roy; M E Rick; K E Higgins; J C McCulloch
Journal:  Br J Ophthalmol       Date:  1986-10       Impact factor: 4.638

2.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

3.  The significance of vitronectin in proliferative diabetic retinopathy.

Authors:  P Esser; M Bresgen; M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

4.  A hypothesis-generating study to evaluate platelet activity in diabetics with chronic kidney disease.

Authors:  Donald F Brophy; Rika J Martin; Todd Wb Gehr; Marcus E Carr
Journal:  Thromb J       Date:  2005-03-29

5.  Elevated heparin-induced antibodies are more common in diabetic patients with vascular disease.

Authors:  Joseph J Naoum; Nibal R Chamoun; Mitul S Patel; Tiffany K Street; Mazen Haydar; Jean Bismuth; Hosam F El-Sayed; Mark G Davies; Alan B Lumsden; Eric K Peden
Journal:  Thrombosis       Date:  2014-02-06

6.  Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation.

Authors:  Grzegorz Gajos; Aleksander Siniarski; Joanna Natorska; Michał Ząbczyk; Jakub Siudut; Krzysztof Piotr Malinowski; Renata Gołębiowska-Wiatrak; Paweł Rostoff; Anetta Undas
Journal:  Cardiovasc Diabetol       Date:  2018-11-22       Impact factor: 9.951

7.  Effects of diabetes mellitus complicated by admission hyperglycemia on clot histological composition and ultrastructure in patients with acute ischemic stroke.

Authors:  Jun Lu; Juan Chen; Daming Wang; Qun Gao; Peng Qi; Junjie Wang; Shen Hu; Ximeng Yang; Jingwen Fan; Ling Li; Yao Lu
Journal:  BMC Neurol       Date:  2022-04-05       Impact factor: 2.474

Review 8.  Coagulatory Defects in Type-1 and Type-2 Diabetes.

Authors:  Amélie I S Sobczak; Alan J Stewart
Journal:  Int J Mol Sci       Date:  2019-12-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.